JP TSE 4592 Pharmaceutical

SanBio Company Limited

サンバイオ株式会社

Net income

−¥3.8B

≈ −$24.3M

Income taxes paid

¥955,000

≈ $6K

Total assets

¥15.6B

≈ $98.9M

Equity ratio

87.1%

Ranked #3,998 among listed Japanese companies by corporate taxes paid.

US dollar amounts use ¥158.0 per dollar.

Annual results

Fiscal year	Revenue	Net income	Tax expense	Taxes paid	Total assets	Net assets	Equity ratio	Source
Jan 2026	—	−¥3.8B	−¥449M	¥955,000	¥15.6B	¥13.6B	87.1%	EDINET (consol.)
Jan 2025	—	−¥2.9B	−¥128M	¥16.2M	¥3.4B	¥1.8B	51.1%	EDINET (consol.)
Jan 2024	—	−¥2.6B	—	—	¥5.0B	¥2.8B	55.3%	EDINET (consol.)
Jan 2023	—	−¥5.6B	—	—	¥7.0B	¥4.4B	62.9%	EDINET (consol.)
Jan 2022	—	−¥4.7B	—	—	¥5.5B	¥2.0B	36.9%	EDINET (consol.)

From annual securities reports filed with the Financial Services Agency's EDINET. 日本語のページ（同業比較・役員）

Compare with the world's largest companies

See where Japanese companies stand in the world rankings by revenue, profit and taxes paid.